Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26.2Revenue (TTM) $M0.3Net Margin (%)-3,655.2Altman Z-Score-40.2
Enterprise Value $M23.8EPS (TTM) $-0.1Operating Margin %-8,963.0Piotroski F-Score2
P/E(ttm)--Beneish M-Score-5.4Pre-tax Margin (%)-3,655.2Higher ROA y-yY
Price/Book4.310-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsN
Price/Sales60.05-y EBITDA Growth Rate %-23.2Current Ratio1.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-71.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-17,349.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M216ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CVM

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CVM is held by these investors:



CVM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KERSTEN GEERT RCEO 2014-10-13Buy14,999$0.77-84.42view
KERSTEN GEERT RCEO 2013-12-30Buy300,000$0.6-80view
KERSTEN GEERT RChief Executive 2013-10-09Buy8,400$0.79-84.81view
YOUNG PETER RDirector 2013-06-19Buy2,500$2.4-95view
KERSTEN GEERT RChief Executive 2013-06-14Buy14,512$2.4-95view
KERSTEN GEERT RCEO 2013-05-20Buy4,000$2.5-95.2view
KERSTEN GEERT RCEO 2013-05-02Buy11,870$2.7-95.56view
YOUNG PETER RDirector 2013-03-27Buy2,500$2.3-94.78view
PRICHEP PATRICIA BSenior Vice President 2013-03-27Buy2,500$2.2-94.55view
KERSTEN GEERT RCEO 2013-03-26Buy34,813$2.1-94.29view

Press Releases about CVM :

Quarterly/Annual Reports about CVM:

News about CVM:

Articles On GuruFocus.com
Updated Coverage Report Focuses on CEL-SCI Corporation Jan 12 2015 
Coverage Initiation Report Focuses on CEL-SCI Corporation Oct 15 2014 
CELSCISci Corp Reports Operating Results (10-Q) Feb 09 2011 
CELSCISci Corp Reports Operating Results (10-Q) Aug 16 2010 
CELSCISci Corp Reports Operating Results (10-Q) May 17 2010 
CELSCISci Corp Reports Operating Results (10-Q) Feb 12 2010 
CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
CELSCISci Corp Reports Operating Results (10-Q/A) Jan 29 2010 
CELSCISci Corp Reports Operating Results (10-K) Jan 13 2010 

More From Other Websites
CEL-SCI Receives Intent to Grant Notice for New Multikine Patent from the European Patent Office Apr 28 2017
CEL-SCI Corporation Releases Letter to Shareholders Apr 24 2017
CEL-SCI Scientist Presents at the World Vaccine Congress Apr 12 2017
CEL-SCI Announces $1.5 Million Registered Direct Offering Mar 09 2017
Blog Coverage CEL-SCI Provides Update on Late-stage Multikine Head and Neck Cancer Study Mar 08 2017
CEL-SCI Gives Update on Partial Clinical Hold on Phase 3 Head and Neck Cancer Study with Multikine Mar 06 2017
Vienna’s Cel-Sci Corp. raises $1 million for head and neck cancer trial Mar 01 2017
CEL-SCI Announces That the NYSE MKT Approves Plan Feb 27 2017
CEL-SCI Scientist Presents New Findings for Rheumatoid Arthritis Treatment Vaccine at Conference Feb 21 2017
Cel-Sci posts 1Q profit Feb 09 2017
CEL-SCI Corporation Reports First Quarter Fiscal 2017 Financial Results Feb 09 2017
CEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern... Dec 20 2016
Cel-Sci reports 4Q loss Dec 14 2016
CEL-SCI Reports Fiscal 2016 Financial Results and Clinical & Corporate Developments Dec 14 2016
CEL-SCI Reports on NYSE MKT Noncompliance Notice and Compliance Plan Dec 09 2016
CEL-SCI Announces Pricing of $4.25 Million Public Offering of Common Stock and Warrants Dec 02 2016
CEL-SCI Announces Proposed Public Offering of Common Stock and Warrants Dec 01 2016
CEL-SCI Submits Response to FDA in Connection with Partial Clinical Hold on Phase 3 Clinical Trial Nov 21 2016
CEL-SCI Reports Preclinical Data Showing LEAPS Vaccine is Successful in Treating Rheumatoid... Nov 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)